MULTIVISCERAL RESECTION FOR COLORECTAL CANCERS: AN ANALYSIS OF PROGNOSTIC FACTORS AND OUTCOMES

1) Department of Surgical Gastroenterology and Liver Transplantation, Sir Ganga Ram Hospital, New Delhi, India.

Disclosure: The author has declared no conflicts of interest.

Received: 15.11.15 Accepted: 04.12.15

  doi: 10.5455/ijsm.surgery01

  Fulltext PDF Download

  EndNote/RefWorks

  Article Statistics

Abstract:

For colorectal cancer patients, long-term survival is achievable only after complete resection of the disease. However, the decision to embark on a multi-visceral resection must be made after weighing the risks against the potential benefits. We retrospectively analyzed the demographics, tumor parameters, perioperative results, oncological outcomes and survival details of 35 patients who underwent multivisceral resection for colorectal carcinoma between 1996 and 2013. 'Multivisceral resection' was defined as the resection of at least one other organ in addition to cancer affected the colon. There were 19 males and 16 females who had a mean age of 52.7 ± 13.6 years. The most common primary site of the tumor was the rectum, followed by the sigmoid, the left, and the right colon. Most frequently resected additional organ was the pancreas followed by the uterus, small bowel, urinary bladder, ureter, vagina, spleen, duodenum, ovary, and liver. Postoperative histopathological examination confirmed tumor infiltration in the adjacent organs in 48.5%. The postoperative complication was developed in 21 (60%) patients. There was no surgery-related mortality. Ten patients had evidence of recurrence at last follow-up in June 2014. The 5-year survival rate was of 73.1% according to Kaplan-Meier survival analysis. Multivisceral resection for colorectal cancer is associated with a high morbidity rate, but the long-term survival is good.

Keywords: Colorectal carcinoma, multivisceral resection, colorectal surgery

References

1. Curado MP, Edwards B, Shin HR, et al. (Eds). Cancer Incidence in Five Continents, Volume IX. IARC Scientific Publication, No 160 IARC, Lyon 2007.
2. Sugarbaker ED. Coincident removal of additional structures in resections for carcinoma of the colon and rectum. Ann Surg 1946; 123: 1036–1046. [DOI via Crossref] [PMC Free Fulltext]
3. Lopez MJ, Monafo VW: Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery 1993, 113:365-72.
4. Hunter JA, Ryan JA, Schutz P. En bloc resection of colon cancer adherent to other organs. Am J Surg 1987;154:67-71. [DOI via Crossref]
5. Gebhardt C, Meyer W, Ruckriegel S, Meier U. Mustivisceral resection of advanced colorectal carcinoma. Langenback's Arch Surg 1999;384:194-9. [DOI via Crossref]
6. Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg 2002;235:217-25. [DOI via Crossref] [Pubmed] [PMC Free Fulltext]
7. Colon and rectum. in: S.B. Edge, S.R. Byrd, C.C. Compton, (Eds.) AJCC Cancer Staging Manual. 7th ed. Springer-Verlag, New York; 2010: 143–164
8. Hermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol 1994;10:12–20. [DOI via Crossref] [Pubmed]
9. Sokmen S, Terzi C, Unek T, Alanyali H, Fuzun M. Multivisceral resections for primary advanced rectal cancer. Int J Colorectal Dis 1999;14:282-5. [DOI via Crossref] [Pubmed]
10. Govindarajan A, Coburn NG, Kiss A, Rabeneck L, Smith AJ, Law CHL: Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst 2006, 98:1474-81.
11. Nakafusa Y, Tanaka T, Tanaka M, Kitajima Y, Sato S, Miyazaki K. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum 2004;47:2055-63. [DOI via Crossref] [Pubmed]
12. Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combinaton of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Br J Surg 2000;87:1553– 62. [DOI via Crossref] [Pubmed]
13. Croner RS, Merkel S, Papadopoulos T, Schellerer V, Hohenberger W, Goehl J. Multivisceral resection for colon carcinoma. Dis Colon Rectum 2009;52:1381-6. [DOI via Crossref] [Pubmed]
14. Radespiel-Troger M, Hohenberger W, Reingruber B. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification. Cancer 2004;100: 958–67. [DOI via Crossref] [Pubmed]
15. Montesani C, Ribotta G, De Milito R, Pronio A, D'Amato A, Narilli P, Jaus M: Extended resection in the treatment of colorectal cancer. Int J Colorectal Dis 1991, 6:161-4.
16. Nelson H, Petrelli N, Carlin A, et al. Guidlines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93:583–96. [DOI via Crossref] [Pubmed]
17. Enda TH, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 1998;41:451–9. [DOI via Crossref]
18. Tang R, Wang JY, Chien CR, Chen JS, Lin SE, Fan HA. The association between perioperative blood transfusion and survival of patients with colorectal cancer. Cancer 1993;72:341–8. [DOI via Crossref]
19. Van de Wartering LM, Brand A, Houbiers JG, et al. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg 2001;88:26772. [DOI via Crossref] [Pubmed]
20. Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998;74(Suppl 2):3159.

How to Cite this Article